BPC-157 Nasal Drops 15 mg

About BPC-157 Nasal Drops

Body Protection Compound-157 (BPC-157) is a 15-amino acid synthetic pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from the protective gastric juice protein BPC. Noted for its pronounced chemical stability in acidic and enzymatic environments, BPC-157 is widely investigated for its pleiotropic reparative mechanisms across musculoskeletal, endothelial, and gastrointestinal tissues. Laboratory models indicate that BPC-157 accelerates the healing of transected tendons and ligaments, upregulates early growth response 1 (EGR-1) and VEGF expression, and promotes cytoprotective nitric oxide modulation. Supplied as a stable 30 mL dropper solution (250 mcg per 0.50 mL, 15 mg total) for precision non-invasive research protocols.

Nasal drops technology & delivery format

BPC-157 Nasal Drops is supplied in the NADOVA LABS precision dropper bottle — a 30 mL cobalt blue light-filtering glass dispensing bottle equipped with a calibrated volumetric pipette for exact laboratory micro-dosing. Formulated to deliver exactly 250 mcg of active peptide per 0.50 mL dropper volume (15 mg total across 30 mL / 60 doses). Authenticated by reverse-phase HPLC (≥99.0% purity) and manufactured under strict cold-chain quality controls with a batch-specific Certificate of Analysis.

Handling & research compliance

These nasal drops are supplied strictly for in-vitro and laboratory research use by qualified scientific investigators. It is not an approved medicine, medical device, food, or supplement, and is not for human or veterinary use, ingestion, or administration. Store refrigerated at 2–8 °C, protect from direct light, and follow accepted laboratory safety procedures. Statements have not been evaluated by any regulatory authority (FDA, EMA).